Long-term follow-up of spontaneous development in a boy with familial male precocious puberty

Hormone Research

Volumn 62, Issue 4, 2004, Pages 177-181

  Partsch, Carl Joachim ^a   Krone, Nils ^b   Riepe, Felix G ^b   Gromoll, Jörg ^c   Sippell, Wolfgang G ^b  

^a KLINIKUM ESSLINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Familial male precocious puberty; LH receptor; Precocious puberty; Pubertal growth spurt; Puberty

Indexed keywords

LUTEINIZING HORMONE RECEPTOR;

ARTICLE; CASE REPORT; DEVELOPMENTAL DISORDER; DEVELOPMENTAL GENETICS; DISEASE COURSE; FAMILIAL DISEASE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GROWTH ACCELERATION; HORMONE RESPONSE; HUMAN; HYPOPHYSIS FUNCTION; LABORATORY TEST; LONGITUDINAL STUDY; MALE; MUTAGENESIS; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ALANINE; AMINO ACID SUBSTITUTION; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; FOLLOW-UP STUDIES; HUMANS; MALE; MUTATION; PROSPECTIVE STUDIES; PUBERTY, PRECOCIOUS; RECEPTORS, LH; TIME FACTORS; VALINE;

EID: 7544235864     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080887     Document Type: Article

References (21)

1. Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jimenez JF, Aiman EJ, DeVane GW, Redman JF, Elders MJ: Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metabol 1981; 52:271-278.
2. Rosenthal SM, Grumbach MM, Kaplan SL: Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): Effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metabol 1983; 57: 571-579.
3. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr: A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652-654.
4. Holland FJ, Kirsch SE, Selby R: Gonadotropin-independent precocious puberty ('testotoxicosis'): Influence of maturational status on response to ketoconazole. J Clin Endocrinol Metabol 1987; 64: 328-333.
5. Laue L, Jones J, Barnes KM, Cutler GB Jr: Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metabol 1993; 76: 151-155.
6. Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB Jr: Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med 1989; 320: 496-502.
7. Bertelloni S, Baroncelli GI, Lala R, Cappa M, Matarazzo P, De Sanctis C, Saggese G: Longterm outcome of male-limited gonadotropinindependent precocious puberty. Horm Res 1997; 48: 235-239.
8. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Stanford, Stanford University Press, 1959.
9. Bayley N, Pinneau SR: Tables for predicting adult height from skeletal age: Revised use with the Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-441.
10. Gromoll J, Partsch CJ, Simoni M, Nordhoff V, Sippell WG, Nieschlag E, Saxena BB: A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metabol 1998; 83:476-480.
11. Latronico AC, Anasti J, Arnhold IJ, Mendonca BB, Domenice S, Albano MC, Zachman K, Wajchenberg BL, Tsigos C: A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metabol 1995; 80: 2490-2494.
12. Latronico AC, Abell AN, Arnhold IJ, Liu X, Lins TS, Brito VN, Billerbeck AE, Segaloff DL, Mendonca BB: A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metabol 1998; 83:2435-2440.
13. Latronico AC, Lins TS, Brito VN, Arnhold IJ, Mendonca BB: The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin Endocrinol 2000; 53: 609-613.
14. Egli CA, Rosenthal SM, Grumbach MM, Montalvo JM, Gondos B: Pituitary gonadotropinindependent male-limited autosomal dominant sexual precocity in nine generations: Familial testotoxicosis. J Pediatr 1985; 106:33-40.
15. Karlberg J, Fryer JG, Engstrom I, Karlberg P: Analysis of linear growth using a mathematical model. II. From 3 to 21 years of age. Acta Paediatr Scand 1987(suppl 337):12-29.
16. Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta 1989(suppl 52):1-125.
17. Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child 1966;41: 454-471.
18. Rosenfield RL: Selection of children with precocious puberty for treatment with gonadotropin-releasing hormone analogs. J Pediatr 1994;124: 989-991.
19. Oerter-Klein K: Precocious puberty: Who has it? Who should be treated? J Clin Endocrinol Metabol 1999; 84: 411-414.
20. Léger J, Reynaud R, Czernichow P: Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment? J Pediatr 2000; 137: 819-825.
21. Partsch CJ, Heger S, Sippell WG: Management and outcome of central precocious puberty. Clin Endocrinol 2002; 56: 129-148.